Your browser doesn't support javascript.
loading
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial.
Cleary, James M; Horick, Nora K; McCleary, Nadine Jackson; Abrams, Thomas A; Yurgelun, Matthew B; Azzoli, Christopher G; Rubinson, Douglas A; Brooks, Gabriel A; Chan, Jennifer A; Blaszkowsky, Lawrence S; Clark, Jeffrey W; Goyal, Lipika; Meyerhardt, Jeffrey A; Ng, Kimmie; Schrag, Deborah; Savarese, Diane M F; Graham, Christopher; Fitzpatrick, Bridget; Gibb, Kathryn A; Boucher, Yves; Duda, Dan G; Jain, Rakesh K; Fuchs, Charles S; Enzinger, Peter C.
Afiliação
  • Cleary JM; Center for Esophageal and Gastric Cancer, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Horick NK; Division of Gastrointestinal Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.
  • McCleary NJ; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Abrams TA; Center for Esophageal and Gastric Cancer, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Yurgelun MB; Division of Gastrointestinal Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.
  • Azzoli CG; Center for Esophageal and Gastric Cancer, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Rubinson DA; Division of Gastrointestinal Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.
  • Brooks GA; Center for Esophageal and Gastric Cancer, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Chan JA; Division of Gastrointestinal Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.
  • Blaszkowsky LS; Steele Laboratories for Tumor Biology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Clark JW; Center for Esophageal and Gastric Cancer, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Goyal L; Division of Gastrointestinal Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.
  • Meyerhardt JA; Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Ng K; Center for Esophageal and Gastric Cancer, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Schrag D; Division of Gastrointestinal Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.
  • Savarese DMF; Vernon Cancer Center, Newton-Wellesley Hospital, Newton, Massachusetts.
  • Graham C; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Fitzpatrick B; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Gibb KA; Center for Esophageal and Gastric Cancer, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Boucher Y; Division of Gastrointestinal Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.
  • Duda DG; Center for Esophageal and Gastric Cancer, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Jain RK; Division of Gastrointestinal Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.
  • Fuchs CS; Center for Esophageal and Gastric Cancer, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Enzinger PC; Division of Gastrointestinal Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.
Cancer ; 125(13): 2213-2221, 2019 07 01.
Article em En | MEDLINE | ID: mdl-30913304
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Junção Esofagogástrica Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Junção Esofagogástrica Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos